Acetazolamide therapy evaluation in haemorrhagic stroke.

Rom J Neurol Psychiatry

Institute of Neurology and Psychiatry, G. Marinescu Hospital.

Published: November 1995

The influence of acetazolamide in patients with hemorrhagic stroke was assessed in 54 patients in comparison with the influence of other therapies in 68 patients included in a control group. Modified Rankin Scale and mortality rate were evaluated at three different moments: onset, 72 hours and control (3 weeks-one month from the onset). A better outcome was seen when acetazolamide was given. Mortality rate was significantly lower in the group of acetazolamide. This therapy may be safely used in haemorrhagic stroke, especially when hydrocephalus is associated.

Download full-text PDF

Source

Publication Analysis

Top Keywords

acetazolamide therapy
8
haemorrhagic stroke
8
mortality rate
8
acetazolamide
4
therapy evaluation
4
evaluation haemorrhagic
4
stroke influence
4
influence acetazolamide
4
acetazolamide patients
4
patients hemorrhagic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!